Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory...

Area of Science:

• Biomaterials Science
• Gastroenterology
• Drug Delivery Systems

Background:

• Inflammatory bowel disease (IBD) affects millions globally, with current treatments often inadequately managing symptoms and impacting quality of life.
• The need for novel therapeutic strategies for IBD is critical due to treatment limitations.

Purpose of the Study:

• To explore the potential of biomaterials-based drug delivery systems for improved inflammatory bowel disease (IBD) management.
• To discuss how targeting specific pathophysiological changes in the IBD gastrointestinal tract can inform the design of advanced drug delivery systems.

Main Methods:

• Review and discussion of biomaterials properties (biocompatibility, sustained release).
• Analysis of pathophysiological alterations in the inflamed colon of IBD patients (pH, surface charge, reactive oxygen species, biomolecules).
• Conceptual framework for designing targeted biomaterial-based systems.

Main Results:

• Biomaterials offer unique advantages for drug delivery in IBD due to their properties.
• Understanding IBD-specific gastrointestinal changes is key for rational design of drug delivery systems.
• Targeting these changes can enhance therapeutic outcomes.

Conclusions:

• Biomaterials-based drug delivery systems represent a promising avenue for developing more effective IBD treatments.
• Tailoring delivery systems to the unique pathophysiological environment of the inflamed colon is crucial for efficient IBD management.
• This approach provides a roadmap for future research in IBD therapeutics.